Topics
The Retina Pipeline
Business Matters: Rethinking Private Equity
Editorially independent content supported with advertising by Bausch + Lomb and Regeneron
View Supplement
Providing Inflammatory Control of Chronic Idiopathic Noninfectious Posterior Uveitis in a Patient With Associated Retinal Vasculitis
Sponsored by Bausch + Lomb
View Insert
Retina Pipeline: A View Into Ongoing Innovation
Editorially independent content supported by advertising from Genentech
View Interactive Supplement
The Surgery Issue
Providing Inflammatory Control in a Patient With Undifferentiated Unilateral Alternating Posterior Uveitis
Evaluating OCT Angiography for Daily Clinical Practice
Sponsored by Heidelberg Engineering Academy
Addressing Barriers to Patient Care: Market Access Challenges With Anti-VEGF Therapies
Supported through an educational grant from Regeneron Pharmaceuticals
Diabetic Eye Disease
Business Matters: From Manager to Leader
Multimodal Imaging: Implications for Clinical Practice
Sponsored by NIDEK
Rare and Inherited Diseases
AREDS Formulation: What We Know Now
Sponsored by MacuHealth
Active Visual Rehabilitation: A New Paradigm in Low Vision Services
Going Beyond the Classroom
Sponsored by Alcon
Clinical Decisions in Noninfectious Posterior Segment Uveitis
Sponsored by Allergan
Sustained-Release Devices for the Treatment of Chronic Eye Diseases
Supported through an educational grant by Allergan and EyePoint Pharmaceuticals.
The Future of Age-Related Macular Degeneration
Business Matters: Keep Your Practice's Data Secure
Providing Inflammatory Control in a Patient With Birdshot Chorioretinopathy
Using Photodynamic Therapy in 2019: Current Concepts for Real-World Use
Supported by a grant from Bausch + Lomb
Imaging and Visualization
Vitreoretinal Surgery in the Digital Age
The Importance of Triple Carotenoid Therapy
Lessons Learned: SubLiminal Laser Therapy for Chronic CSC
Sponsored by Quantel Medical
Women in Retina
Business Matters: Optimizing Your Online Reputation
Successful Management of Uveitis in a Patient With Unilateral Multifocal Choroiditis
Treating Symptomatic Floaters With LFT
Sponsored by Ellex
Closing the Gap in Diabetic Retinopathy: Data From the Latest Studies
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Surgical Techniques and Technologies
Selecting the Right Tools for the Job
2RT: Earlier Intervention for AMD
Diabetic Retinopathy: Changing Treatment Paradigms
Editorially Independent Content Supported With Advertising From Genentech and Carl Zeiss Meditec
Topcon Euretina 2018
Sponsored by Topcon University
Free Print Subscription
Email Newsletter
Conference Calendar
April 17, 2026
Phase 1 Data for Vamikibart Published in JAMA Ophthalmology
MeiraGTx Announces the Acquisition of XLRP Therapy From J&J
April 16, 2026
Experimental Light-Activated Therapy Shows Early Promise for Retinitis Pigmentosa
April 15, 2026
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply for Ophthalmic Program